Cost-Effectiveness of Mammography, MRI, and Ultrasonography for Breast Cancer Screening (Q37792255)

23 August 2017

title

Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening (English)

1 reference

23 August 2017

Cost-Effectiveness of Mammography, MRI, and Ultrasonography for Breast Cancer Screening (English)

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

cost-effectiveness analysis

19 July 2024

main subject

1 reference

based on heuristic

inferred from title

magnetic resonance imaging

0 references

1 reference

1 reference

Stephen Feig

1

1 reference

23 August 2017

language of work or name

1 reference

1 September 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0033838910000837?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

https://api.elsevier.com/content/article/PII:S0033838910000837?httpAccept=text/plain

19 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Radiologic Clinics of North America

19 July 2024

published in

1 reference

23 August 2017

volume

48

1 reference

23 August 2017

issue

5

1 reference

23 August 2017

page(s)

879-891

1 reference

The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening

19 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004

19 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Increased benefit from shorter screening mammography intervals for women ages 40-49 years

19 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Estimation of currently attainable benefit from mammographic screening of women aged 40-49 years

19 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Diagnostic performance of digital versus film mammography for breast-cancer screening

19 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost-effectiveness of digital mammography breast cancer screening

19 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Screening mammography in women aged 40-49 years: analysis of cost-effectiveness

19 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost Analysis of Aggressive Breast Cancer Screening

19 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Screening for breast cancer

19 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Mammographic screening of women aged 40-49 years. Benefit, risk, and cost considerations

19 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost-Effectiveness of Extending Screening Mammography Guidelines To Include Women 40 to 49 Years of Age

19 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast cancer mortality after screening mammography in British Columbia women

19 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness

19 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

19 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Sensitivity analysis in the cost-effectiveness of breast cancer screening

19 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

The cost-effectiveness of breast cancer screening

19 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Computer-aided detection of breast cancer: a cost-effectiveness study

19 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Induced costs of low-cost screening mammography

19 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Performance benchmarks for screening mammography

19 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Identifying minimally acceptable interpretive performance criteria for screening mammography

19 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

The probably benign assessment

19 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Use of breast core biopsy in the United States: results of a national survey

19 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

The evolving practice pattern of the breast surgeon with disappearance of open biopsy for nonpalpable lesions.

19 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

A prospective review of the decline of excisional breast biopsy

19 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy

19 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Stereotactic breast biopsy

19 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

A comparison of Medicare reimbursement and results for various imaging-guided breast biopsy techniques

19 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer

19 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Reducing the cost of diagnosis of breast carcinoma: impact of ultrasound and imaging-guided biopsies on a clinical breast practice

19 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Stereotactic breast biopsy as an alternative to open excisional biopsy

19 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model

19 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Needle core biopsy guided with mammography: a study of cost-effectiveness

19 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Screening mammography: costs and use of screening-related services

19 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial

19 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Ten-year risk of false positive screening mammograms and clinical breast examinations.

19 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost-effectiveness of image-guided core needle biopsy versus surgery in diagnosing breast cancer

19 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

American Cancer Society guidelines for breast cancer screening: update 2003.

19 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

American College of Radiology guidelines for breast cancer screening

19 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

19 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Screening for breast cancer: an update for the U.S. Preventive Services Task Force

19 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms

19 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials

19 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update

19 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

The Canadian National Breast Screening Study: a critical review

19 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast cancer: computer simulation method for estimating optimal intervals for screening

19 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care

19 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost of breast cancer treatment. A 4-year longitudinal study

19 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast cancer screening by mammography in Norway. Is it cost-effective?

19 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review

19 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors

19 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Advanced breast cancer and its prevention by screening

19 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Is mass screening for breast cancer cost-effective?

19 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost-effective management of breast cancer

19 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost-benefit determinations in screening mammography

19 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

19 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer

19 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

19 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.

19 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results

19 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination

19 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study

19 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series

19 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma

19 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer

19 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

19 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis

19 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast Cancer Screening With Imaging: Recommendations From the Society of Breast Imaging and the ACR on the Use of Mammography, Breast MRI, Breast Ultrasound, and Other Technologies for the Detection of Clinically Occult Breast Cancer

19 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging

19 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers

19 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer

19 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women

19 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

19 July 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

19 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer

19 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

19 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Familial risks of breast cancer

19 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Lobular Carcinoma In Situ of the Breast

19 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast cancer risk associated with proliferative breast disease and atypical hyperplasia

19 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study

19 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Mammographic Density and the Risk and Detection of Breast Cancer

19 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Tailored supplemental screening for breast cancer: what now and what next?

19 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US.

19 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Analysis of clinically occult and mammographically occult breast tumors

19 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Effect of age, breast density, and family history on the sensitivity of first screening mammography

19 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico

19 July 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands

19 July 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers

19 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Imaging of the radiographically dense breast

19 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Analysis of parenchymal density on mammograms in 1353 women 25-79 years old.

19 July 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Malignant breast masses detected only by ultrasound. A retrospective review

19 July 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Occult cancer in women with dense breasts: detection with screening US--diagnostic yield and tumor characteristics.

19 July 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Incidental findings on sonography of the breast: clinical significance and diagnostic workup

19 July 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Clinically and mammographically occult breast lesions: detection and classification with high-resolution sonography

19 July 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Clinical utility of bilateral whole-breast US in the evaluation of women with dense breast tissue

19 July 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations

19 July 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density

19 July 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Using sonography to screen women with mammographically dense breasts

19 July 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Auditing and benchmarks in screening and diagnostic mammography

19 July 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer

19 July 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost

19 July 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Providing professional mammography services: financial analysis

19 July 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts

19 July 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.RCL.2010.06.002

19 July 2024

Identifiers

1 reference

23 August 2017

1 reference